VisionGate is a pioneering biotechnology company at the forefront of lung cancer detection and prevention. Our innovative non-intrusive testing, coupled with advanced 3D cell imaging and AI-powered detection, allows us to identify lung cancer in high-risk patients with greater accuracy and efficiency. With just a simple sputum sample, our cutting-edge technology can detect lung cancer much earlier than traditional methods, providing you with the opportunity to take proactive measures towards your health.

We believe in early detection to ensure you can continue living your life to the fullest. Our patented Cell-CT imaging captures high-resolution 3D images of individual cells, providing hundreds of disease indicators and molecular markers per cell. With over 164 owned patents globally and more pending, VisionGate is committed to revolutionizing lung cancer detection and saving lives.

Partner with us or contact us today for more information